SHOULDER INNOVATIONS, INC.

The company develops and commercializes medical technology solutions focused on shoulder surgical care. Its offerings center on advanced implant systems for anatomic and reverse total shoulder arthroplasty, featuring proprietary glenoid and humeral stem technologies designed to improve stability and joint biomechanics. Complementing its implants, the company provides AI- and machine-learning-driven preoperative planning software that converts medical scans into 3D patient models, alongside a streamlined two-tray surgical instrumentation system. It serves orthopedic surgeons, hospitals, and outpatient surgery centers, supported by specialized clinical personnel and independent distributors.

The business operates commercially within the United States, targeting high-volume orthopedic surgeons across inpatient facilities and ambulatory surgery centers. Its implant portfolio has been utilized in more than 17,500 surgical procedures. Commercial and clinical operations are supported by a field team of 45 shoulder specialists collaborating with a third-party distributor network. The provided text does not state the location of the company's corporate headquarters.

Summary of the business section of Shoulder Innovations's latest annual report, written by StockData.